{"title":"Deep Learning-Based Estimation of Myocardial Material Parameters from Cardiac MRI.","authors":"Yunhe Chen, Xiwen Zhang, Yongzhong Huo, Shuo Wang","doi":"10.3390/bioengineering12040433","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Accurate estimation of myocardial material parameters is crucial to understand cardiac biomechanics and plays a key role in advancing computational modeling and clinical applications. Traditional inverse finite element (FE) methods rely on iterative optimization to infer these parameters, which is computationally expensive and time-consuming, limiting their clinical applicability.</p><p><strong>Methods: </strong>This study proposes a deep learning-based approach to rapidly and accurately estimate the left ventricular myocardial material parameters directly from routine cardiac magnetic resonance imaging (CMRI) data. A ResNet18-based model was trained on FEM-derived parameters from a dataset of 1288 healthy subjects.</p><p><strong>Results: </strong>The proposed model demonstrated high predictive accuracy on healthy subjects, achieving mean absolute errors of 0.0146 for Ca and 0.0139 for Cb, with mean relative errors below 5.00%. Additionally, we evaluated the model on a small pathological subset (including ARV and HCM cases). The results revealed that while the model maintained strong performance on healthy data, the prediction errors in the pathological samples were higher, indicating increased challenges in modeling diseased myocardial tissue.</p><p><strong>Conclusion: </strong>This study establishes a computationally efficient and accurate deep learning framework for estimating myocardial material parameters, eliminating the need for time-consuming iterative FE optimization. While the model shows promising performance on healthy subjects, further validation and refinement are required to address its limitations in pathological conditions, thereby paving the way for personalized cardiac modeling and improved clinical decision-making.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 4","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12024853/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12040433","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Accurate estimation of myocardial material parameters is crucial to understand cardiac biomechanics and plays a key role in advancing computational modeling and clinical applications. Traditional inverse finite element (FE) methods rely on iterative optimization to infer these parameters, which is computationally expensive and time-consuming, limiting their clinical applicability.
Methods: This study proposes a deep learning-based approach to rapidly and accurately estimate the left ventricular myocardial material parameters directly from routine cardiac magnetic resonance imaging (CMRI) data. A ResNet18-based model was trained on FEM-derived parameters from a dataset of 1288 healthy subjects.
Results: The proposed model demonstrated high predictive accuracy on healthy subjects, achieving mean absolute errors of 0.0146 for Ca and 0.0139 for Cb, with mean relative errors below 5.00%. Additionally, we evaluated the model on a small pathological subset (including ARV and HCM cases). The results revealed that while the model maintained strong performance on healthy data, the prediction errors in the pathological samples were higher, indicating increased challenges in modeling diseased myocardial tissue.
Conclusion: This study establishes a computationally efficient and accurate deep learning framework for estimating myocardial material parameters, eliminating the need for time-consuming iterative FE optimization. While the model shows promising performance on healthy subjects, further validation and refinement are required to address its limitations in pathological conditions, thereby paving the way for personalized cardiac modeling and improved clinical decision-making.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering